[HTML][HTML] Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton …

C Chrenek, B Duong, A Khullar, C McRee… - Frontiers in …, 2024 - frontiersin.org
Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …

[HTML][HTML] Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton …

C Chrenek, B Duong, A Khullar, C McRee… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta …

C Chrenek, B Duong, A Khullar… - Frontiers in …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta …

C Chrenek, B Duong, A Khullar, C McRee… - Frontiers in …, 2023 - europepmc.org
Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta …

C Chrenek, B Duong, A Khullar, C McRee… - Frontiers in …, 2024 - europepmc.org
Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …